A number of presentations will be given by SFARI Investigators and SFARI staff at the International Society for Autism Research (INSAR) 2018 Annual Meeting in Rotterdam, Netherlands (May 9-12).
A selection of these talks is highlighted below:
Mark H. Johnson, Ph.D. (Birkbeck College, University of London)
Keynote address:
Babies at-risk for autism: Assumptions, progress and prospects
James C. McPartland, Ph.D. (Yale University)
Oral session presentation:
The Autism Biomarkers Consortium for Clinical Trials: Study design and progress to interim analysis
Stephan Sanders, B.M.B.S., Ph.D. (University of California, San Francisco)
Oral session presentation:
Characterization of SCN2A haploinsufficiency in early neurodevelopment using transcriptomic analyses and systems biology
Frederick Shic, Ph.D. (Seattle Children’s Research Institute, University of Washington)
Oral session presentation:
The Autism Biomarkers Consortium for Clinical Trials: Eye tracking interim analyses
John Spiro, Ph.D. (Simons Foundation)
Sponsor presentation:
Simons Foundation update
Jennifer Tjernagel, M.S. (Simons Foundation)
Oral presentation (as part of the following Special Interest Group):
Promoting partnerships between patient advocacy groups and researchers to improve autism research
SFARI staff will also be presenting a number of posters about SFARI projects and resources, including the latest results from SPARK. Click here for more details.
